New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 12, 2014
08:29 EDTCNCCentene price target raised to $84 from $78 at Leerink
Leerink raised its price target for Centene shares to $84 following the company's investor day and keeps an Outperform rating on the stock. The firm believes Centene's medium-term growth story remains solid.
News For CNC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 28, 2015
06:06 EDTCNCCentene sees FY15 EPS $2.60-$2.72, consensus $2.63
Sees FY15 premium and service revenues $20.5B-$21B.
06:05 EDTCNCCentene reports Q1 EPS 52c, consensus 48c
Subscribe for More Information
April 27, 2015
15:04 EDTCNCNotable companies reporting before tomorrow's open
Subscribe for More Information
08:04 EDTCNCCentene appoint Ken Yamaguchi to EVP and Chief Medical Officer
Centene announced the appointment of Ken Yamaguchi to Executive Vice President and Chief Medical Officer, effective immediately. Yamaguchi currently is the Sam & Marilyn Fox Distinguished Professor of Orthopaedic Surgery at Washington University and will continue in that role as part-time faculty. Centene also announced the appointment of Mary Mason to Senior Vice President and Chief Medical Officer of Specialty Companies.
April 17, 2015
08:04 EDTCNCCentene's Nurtur receives full URAC accreditation
Centene announced that Nurtur, its health and wellness subsidiary, received full Disease Management Accreditation from URAC, a Washington, DC-based healthcare accrediting organization that establishes quality standards for the healthcare industry.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use